US 12220415
WEE1 kinase inhibitors and methods of treating cancer using the same
granted A61KA61K31/495A61K31/519
Quick answer
US patent 12220415 (WEE1 kinase inhibitors and methods of treating cancer using the same) held by The Regents of the University of Colorado, a Body Corporate expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/495, A61K31/519, A61K31/635, A61K31/704